News

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Weight Loss Drugs and Their Implications on Medicare: What You Need to Know More weight loss drugs have been approved for coverage by Medicare, but what are the challenges potential ...
Medicare is barred under a 2003 law from paying for weight-loss medications like Wegovy. Lawmakers on Thursday reintroduced a bill that would expand Medicare coverage to the drugs.